Search Results 491-500 of 16989 for pharmacogenetics
Marla Broadfoot, Ph.D. April 14, 2022. Mayo Clinic researchers load CAR-T cells with oncolytic virus to treat solid cancer tumors.
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells ...
Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...
The purpose of this study is to identify changes to the metabolome (range of chemicals produced in the body) and microbiome (intestine microbe environment) that ...
The purpose of this study is to evaluate the feasibility of successfully obtaining serial finger-prick blood samples from castrate resistant prostate cancer and ...
A Study of to assess the Volume of Stomach Contents after Patients have Taken Oral Medications and Sips of Water, before Surgery with Anesthesia.
Learn about postdoctoral education opportunities in Mayo Clinic's Molecular Pharmacology of G Protein-Coupled Receptors Lab led by Laurence J. Miller, M.D..
The purpose of this study is to investigate the gene transcriptional profiles of normal biceps muscles and use them as our control for our study in acquired ...
[MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.